NCT04386057 2025-02-12LY3214996 +/- HCQ in Pancreatic CancerDana-Farber Cancer InstitutePhase 2 Completed52 enrolled 17 charts
NCT02857270 2022-11-22A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerEli Lilly and CompanyPhase 1 Completed210 enrolled